Subscribe To
Neurobo to present at the h.c. wainwright 7th annual nash investor conference
BOSTON , Oct. 17, 2023 /PRNewswire/ -- NeuroBo Pharmaceuticals, Inc. (Nasdaq: NRBO), a clinical-stage biotechnology company on a quest to transform ...
October 17, 2023, 8:01 am
89bio to participate in the h.c. wainwright 7ᵗʰ annual nash investor conference
SAN FRANCISCO, Oct. 17, 2023 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and...
October 17, 2023, 8:00 am
: novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences
Novo Nordisk A/S NVODK:NOVO.B said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. Ocedurenone is...
October 16, 2023, 11:11 am
Novo nordisk buys blood pressure treatment to bolster diabtetes portfolio
Novo Nordisk (NYSE:NVO) has agreed to buy ocedurenone, a blood pressure drug for with potential applications in ...
October 16, 2023, 10:44 am
Novo nordisk buys hypertension drug in $1.3 billion deal
Novo Nordisk (NVO) agreed to buy ocedurenone, a drug that treats uncontrolled hypertension and has the potential to be used in cases of ...
October 16, 2023, 9:50 am
Novo nordisk in $1.3 bln deal to buy hypertension drug
Novo Nordisk has agreed to buy ocedurenone, a drug for uncontrolled hypertension with potential application in ...
October 16, 2023, 7:12 am
Novo nordisk to buy hypertension treatment from for $1.3 billion from kbp biosciences
Novo Nordisk A/S NVO, +1.96% NOVO.B, +0.08% said Monday it will pay $1.3 billion to KBP Biosciences to buy ocedurenone for uncontrolled hypertension. ...
October 16, 2023, 7:11 am
Ecg devices market revenue to cross us$ 12.15 billion at 7.4% cagr by 2033| persistence market research
Explore the growing ECG devices market driven by healthcare advancements, technology innovations, and rising health awareness New York, Oct. 12, 2023 ...
October 12, 2023, 12:09 pm
Davita says news of ozempic's potential in treating kidney disease may have only limited impact for patients, says further studies will be needed
Dialysis company DaVita Inc. DVA, -16.86% issued a statement on Thursday in response to the news Wednesday from Novo Nordisk that its Ozempic treatmen...
October 12, 2023, 8:43 am
Windtree to present at the thinkequity conference on october 19th in new york city
WARRINGTON, Pa., Oct. 12, 2023 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology...
October 12, 2023, 7:30 am
Haemonetics (hae) announces agreement to acquire opsens
Haemonetics' (HAE) acquisition of OpSens will expand its leadership in the interventional cardiology ma...
October 11, 2023, 12:47 pm
This full-body workout fits in a backpack
Rucking, which is simply walking with a weighted backpack, is a great way to combine strength training and car...
October 11, 2023, 9:44 am
Why shares of 89bio plummeted on tuesday
89bio is a clinical-stage biotech company. It focuses on treatments for liver and cardiometabolic disea...
October 10, 2023, 4:13 pm
Opsens stock soars on takeover deal with haemonetics
Opsens Inc shares surged 47% to $2.84 in midday trading on Tuesday after the cardiology-focused medica...
October 10, 2023, 12:24 pm
Alnylam (alny) receives crl for the label expansion of onpattro
Alnylam's (ALNY) label expansion-seeking application for Onpattro, to treat transthyretin-mediated amyloidosis with ...
October 10, 2023, 12:01 pm
Windtree to participate in the lytham partners fall 2023 investor conference on october 17th
WARRINGTON, Pa., Oct. 10, 2023 (GLOBE NEWSWIRE) — Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnolog...
October 10, 2023, 11:30 am
cardiol therapeutics says study results show positive effects of subcutaneously administered cannabidiol
cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) has reported positive study results showing that cannabidi...
October 10, 2023, 8:15 am
Dr. john strobeck scholarship for future doctors offers $1,000 to support aspiring medical professionals
NEW MILFORD, N.J., Oct. 09, 2023 (GLOBE NEWSWIRE) — Future doctors in the United States have a unique opportunity to further their medical education...
October 9, 2023, 4:05 pm
Alnylam to scrap snda for patisiran after receiving fda complete response letter
Alnylam Pharmaceuticals Inc. ALNY, -1.00% said Monday it would no longer pursue its supplemental new drug application (sNDA) for patisiran as a treatm...
October 9, 2023, 7:43 am
Newamsterdam pharma's pioneering pulse on alzheimer's breakthroughs
New clinical data shows the potential of obicetrapib in treating early Alzheimer's disease in patients with the ApoE4 mutation. The Phase IIa trial de...
October 2, 2023, 9:26 pm